Happy science Friday and here’s a TGIF list of recent stem cell news and papers. The FDA warning letter to Richard Burt of Northwestern related to noncompliance issues with his stem cell clinic trial for MS has dominated the news recently, but some other notable things have happened as well on stem cells and more …
The Trump FDA commissioner nominee Dr. Scott Gottlieb could dramatically alter how the agency regulates investigational stem cell therapies. How might such changes unfold? There are potential upsides and downsides to the seismic shift that could be in the offing. Gottlieb has written in the past about his perception of FDA over-regulation of stem cells such …
How Scott Gottlieb may transform the FDA’s approach to stem cells Read More »
The Scientists March on Washington (aka March for Science @ScienceMarchDC) is one of the biggest science movements I’ve ever seen. It’s gone from zero to sixty in about 2 seconds now with hundreds of thousands of supporters, but some important questions are arising about this event and its organizers. I continue to be enthusiastic about the March, but this week I’ve …
4 key questions for March for Science organizers & what info I gathered on them Read More »
Former Texas governor Rick Perry, now the Trump Department of energy (DoE) nominee, has a long association with the Texas stem cell clinic, Celltex. He was a patient of Celltex, which some years back infused Perry with non-FDA approved stem cells. The company received a warning letter from the FDA and since that time has …
Rick Perry resigns from stem cell clinic Celltex, where he earned $175K Read More »
What’s the deal with Trump’s HHS Secretary pick Rep. Tom Price (now testifying before the Senate) and the amniotic tissue/stem cell company MiMedx that’s caused some buzz in the last 48 hours? I’ve been following MiMedx for a few years since it received an untitled letter from the FDA and I noted its claim of one its …
What are the latest developments in stem cells and regenerative medicine in this first week of 2017 and right before the end of the past year? Here are some of the headlines and papers that have popped up that seem notable or surprising. Be sure to also check out our stem cell & regenerative medicine …
TGIF: Week’s Stem Cell Headlines, Papers, & Resources Read More »
Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions. …
The money behind a piece of legislation can provide unique insights into the back story and this is definitely true for the REGROW Act that would reduce FDA oversight of the investigational use of stem cells in patients. Senator Mark Kirk of Illinois, who is facing probable defeat next week in his reelection bid according to …
REGROW Act, Mark Kirk Lobbying & Contributions Yield Stem Cell Surprises Read More »
We’ve bottled the power of giant pumpkin stem cell magic and are providing it to the world! Giant Pumpkin Stem Cell Elixir Anti-aging Supplement & Cream-In-OneTM is your ticket to a better life. What does this stem cell supplement do? It’s all good and huge! Celebrities are some of our biggest customers. Even if they …
Giant Pumpkin Stem Cell Supplement Cream: Halloween Satire Read More »
Does the new gene editing method NgAgo work or not? If not, what happened? The answers to both questions seem to depend on who you ask and what you read. As much as CRISPR has been the revolutionary in the genetic modification technology arena over past methods, could CRISPR itself in the next few years …
Controversy over CRISPR challenger NgAgo irreproducibility reported Read More »